• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转铁蛋白偶联囊泡系统用于癌症的细胞内药物递送:开发与表征。

Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.

机构信息

Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar (M.P.), India.

出版信息

J Drug Target. 2012 May;20(4):372-80. doi: 10.3109/1061186X.2012.662687. Epub 2012 Feb 18.

DOI:10.3109/1061186X.2012.662687
PMID:22339366
Abstract

OBJECTIVES

In the present study attempt has been made to enhance the selective tumor cell killing in mouse xenograft model using DQAsomes as a mitochondriotropic carrier and transferrin (Tf) as a ligand to target tumor cells.

METHODS

Tf modified DQAsomes (Tf-DQAsomes) were prepared by incubating preformed paclitaxel loaded DQAsomes with Tf in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. Developed systems were characterized for size and size distribution, entrapment efficiency, and in vitro drug release. Fluorescence microscopy and flow cytometry were performed to evaluate cellular uptake of the carriers. Antitumor activity was determined using HeLa cells. In vivo therapeutic efficacy was determined in xenograft mouse model.

KEY FINDINGS

Uptake studies demonstrated that Tf-DQAsomes result in higher fluorescence intensity to the cancer cells as compared to plain DQAsomes. Tf-DQAsomes exhibited better antitumor activity in vitro as compared to plain DQAsomes and paclitaxel solution. In vivo biodistribution study revealed that paclitaxel concentration in the tumor was much higher in the case of Tf-DQAsomes as compared to plain DQAsomes and paclitaxel solution; however in other organs it was much lower than the latter two formulations. Tf-DQAsomes exhibited significant antitumor activity in the mouse xenograft model.

CONCLUSIONS

The finding demonstrated that Tf conjugated DQAsomes can effectively be delivered to the tumor in vivo and exhibit significant antitumor activity.

摘要

目的

本研究试图通过 DQAsomes 作为靶向肿瘤细胞的线粒体载体和转铁蛋白(Tf)作为配体,增强小鼠异种移植模型中肿瘤细胞的选择性杀伤。

方法

Tf 修饰的 DQAsomes(Tf-DQAsomes)是通过在 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐存在下,将预形成的紫杉醇负载的 DQAsomes 与 Tf 孵育来制备的。对开发的系统进行了大小和粒径分布、包封效率和体外药物释放的特性研究。荧光显微镜和流式细胞术用于评估载体的细胞摄取。使用 HeLa 细胞测定抗肿瘤活性。在异种移植小鼠模型中测定体内治疗效果。

主要发现

摄取研究表明,与普通 DQAsomes 相比,Tf-DQAsomes 导致癌细胞的荧光强度更高。与普通 DQAsomes 和紫杉醇溶液相比,Tf-DQAsomes 表现出更好的体外抗肿瘤活性。体内生物分布研究表明,与普通 DQAsomes 和紫杉醇溶液相比,Tf-DQAsomes 使肿瘤中的紫杉醇浓度更高;然而,在其他器官中,其浓度远低于后两种制剂。Tf-DQAsomes 在小鼠异种移植模型中表现出显著的抗肿瘤活性。

结论

研究结果表明,Tf 缀合的 DQAsomes 可以有效地递送到体内肿瘤,并表现出显著的抗肿瘤活性。

相似文献

1
Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.转铁蛋白偶联囊泡系统用于癌症的细胞内药物递送:开发与表征。
J Drug Target. 2012 May;20(4):372-80. doi: 10.3109/1061186X.2012.662687. Epub 2012 Feb 18.
2
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.使用转铁蛋白修饰的隐形脂质体实现阿霉素的靶向递送。
Int J Pharm. 2009 May 21;373(1-2):116-23. doi: 10.1016/j.ijpharm.2009.01.023. Epub 2009 Feb 4.
3
Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.载紫杉醇的叶酸修饰和 TAT 肽偶联聚乙二醇化聚合物脂质体的制备、表征及抗肿瘤活性。
J Drug Target. 2011 Jun;19(5):373-81. doi: 10.3109/1061186X.2010.504266. Epub 2010 Aug 2.
4
Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.负载游离紫杉醇的聚乙二醇化紫杉醇纳米粒:制备及其与其他紫杉醇制剂的体内外比较
Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032. Epub 2014 May 22.
5
Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.载紫杉醇的聚(N-乙烯基吡咯烷酮)-b-聚(ε-己内酯)纳米粒的制备及其体内抗肿瘤活性。
J Control Release. 2010 Mar 19;142(3):438-46. doi: 10.1016/j.jconrel.2009.11.002. Epub 2009 Nov 5.
6
Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.新型抗肿瘤策略:载聚乙二醇-羟基喜树碱的转铁蛋白-聚乙二醇-纳米粒子。
J Control Release. 2010 Jan 4;141(1):22-9. doi: 10.1016/j.jconrel.2009.08.024. Epub 2009 Sep 4.
7
Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.紫杉醇脂质体-微泡复合物作为超声触发的治疗性药物输送载体。
J Control Release. 2013 Mar 28;166(3):246-55. doi: 10.1016/j.jconrel.2012.12.025. Epub 2013 Jan 7.
8
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.环肽 RGD 修饰的聚乙二醇-共-聚乳酸胶束增强紫杉醇抗脑胶质瘤作用。
J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.
9
Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.用转铁蛋白和普朗尼克(R)P85对载紫杉醇的聚乳酸-羟基乙酸共聚物纳米粒进行表面修饰,大鼠模型的体外细胞系和体内生物分布研究。
J Drug Target. 2009 Aug;17(7):533-42. doi: 10.1080/10611860903046628.
10
Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.水溶性白蛋白结合型姜黄素纳米粒的制备及抗肿瘤活性的改善。
Int J Pharm. 2011 Jan 17;403(1-2):285-91. doi: 10.1016/j.ijpharm.2010.10.041. Epub 2010 Oct 28.

引用本文的文献

1
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review.为什么化疗药物在肺癌治疗中的药理前景可能与纳米结构最密切相关?铂类药物在非小细胞肺癌和小细胞肺癌治疗中的作用及其意想不到的可能相互作用。综述。
Int J Nanomedicine. 2024 Sep 14;19:9503-9547. doi: 10.2147/IJN.S469217. eCollection 2024.
2
Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors.纳米颗粒在肺癌治疗中的应用:以受体为重点
Front Pharmacol. 2022 Jan 10;12:781425. doi: 10.3389/fphar.2021.781425. eCollection 2021.
3
Biomacromolecules as carriers in drug delivery and tissue engineering.
生物大分子作为药物递送和组织工程中的载体。
Acta Pharm Sin B. 2018 Jan;8(1):34-50. doi: 10.1016/j.apsb.2017.11.005. Epub 2017 Dec 9.
4
Nanotechnology inspired tools for mitochondrial dysfunction related diseases.受纳米技术启发的用于治疗线粒体功能障碍相关疾病的工具。
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):52-69. doi: 10.1016/j.addr.2015.12.024. Epub 2016 Jan 9.